{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"feade39997d4957780743ab96baba4cfbb5ff4990b57a56520c11862727c2203","attributes":{"feedName":"fda","feedSource":"fda","title":"Lannett Issues Voluntary Nationwide Recall Of Levetiracetam Oral Solution, 100mg/Ml Due To Microbial Contamination","description":"Lannett Company, Inc. today announced that it is voluntarily recalling two (2) lots of Levetiracetam Oral Solution, 100mg/mL to the consumer level due to contamination with Bacillus subtilis. The Bacillus subtilis was identified during an evaluation of a raw material used to manufacture the product","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lannett-issues-voluntary-nationwide-recall-levetiracetam-oral-solution-100mgml-due-microbial","publicationDate":"2019-12-19T23:07:17.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers"],"categories":["drugs"],"contaminants":["other"],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"possible","token":"5dfc0424208e61000104023a"}}}